CPT code 43882 denotes surgical revision or removal of gastric neurostimulator electrodes, including explantation of the device when it fails or is no longer needed. This procedure is used in the management of refractory gastroparesis-related nausea and vomiting, most commonly in patients whose symptoms have not improved with medical therapy. The code captures a focused surgical service critical to ongoing neuromodulation care and device lifecycle management.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national overview of the clinical context for the code, the typical service setting, and the payer mix considered in benchmarking and coverage discussions. The publication summarizes what to expect in terms of service classification and clinical rationale, and points to areas where payers commonly define coverage criteria for device removal or revision. Data not available in the input are noted where applicable, and the content aims to clarify the code's purpose and relevance for clinicians, billing staff, and policy analysts working at the intersection of surgical care and device management.